Sanofi
SNY
$49.36
Share price
5.90%
Change (1 day)
-12.81%
Change (1 year)
Categories
Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthélabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
Sanofi (SNY) - Total assets
Total assets on the balance sheet as of December 2023 : $139.81 B
According to Sanofi's latest financial reports the company's total assets are $139.81 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Sanofi - Total assets on balance sheet (from 2002 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $139.81 B | 3.02% |
| 2022-12-31 | $135.71 B | -0.34% |
| 2021-12-31 | $136.17 B | -7.93% |
| 2020-12-31 | $147.89 B | 17.22% |
| 2019-12-31 | $126.17 B | -1% |
| 2018-12-31 | $127.45 B | 6.36% |
| 2017-12-31 | $119.82 B | 8.74% |
| 2016-12-31 | $110.19 B | -1.5% |
| 2015-12-31 | $111.87 B | -5.55% |
| 2014-12-31 | $118.44 B | -10.71% |
| 2013-12-31 | $132.65 B | -0.11% |
| 2012-12-31 | $132.80 B | 1.79% |
| 2011-12-31 | $130.47 B | 15.04% |
| 2010-12-31 | $113.41 B | -1.36% |
| 2009-12-31 | $114.97 B | 14.25% |
| 2008-12-31 | $100.63 B | -4.16% |
| 2007-12-31 | $105.00 B | 2.15% |
| 2006-12-31 | $102.79 B | 0.13% |
| 2005-12-31 | $102.66 B | -11.32% |
| 2004-12-31 | $115.76 B | 844.89% |
| 2003-12-31 | $12.25 B | 21.41% |
| 2002-12-31 | $10.09 B | -5.01% |
| 2001-12-31 | $10.62 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 19.84% | 🇺🇸 USA |
 Novartis NVS | $99.94 B | -28.52% | 🇨🇭 Switzerland |
 Pfizer PFE | $226.50 B | 62.00% | 🇺🇸 USA |
 Novo Nordisk NVO | $46.57 B | -66.69% | 🇩🇰 Denmark |
 Abbott Laboratories ABT | $73.21 B | -47.64% | 🇺🇸 USA |
 Eli Lilly LLY | $64.00 B | -54.22% | 🇺🇸 USA |
 Merck MRK | $106.67 B | -23.70% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $95.15 B | -31.94% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $75.11 B | -46.28% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $43.47 B | -68.90% | 🇮🇱 Israel |